Ben Butkus

5 days ago | 360dx.com | Ben Butkus

NEW YORK – Diagnostics for the Real World, colloquially referred to as DRW, spun out of the University of Cambridge more than 20 years ago. But in many ways, the molecular diagnostics firm resembles a newly minted startup as it prepares for the imminent launch of a retooled version of its rapid, multiplexed, point-of-care molecular diagnostics platform and six new test panels.

1 week ago | 360dx.com | Ben Butkus

VIENNA – Testing for an RNA biomarker of cytomegalovirus (CMV) infection rather than using well-established viral DNA assays may enable better therapeutic management of the infection in immunocompromised patients, according to a presentation at the European Society of Clinical Microbiology and Infectious Diseases global congress held here this week.

Nov 22, 2024 | 360dx.com | Ben Butkus

VANCOUVER, British Columbia — At the Association for Molecular Pathology annual meeting here this week, leadership briefed members on what to expect as the association's lawsuit challenging the US Food and Drug Administration's final rule on laboratory-developed test regulation unfolds.

May 9, 2024 | 360dx.com | Ben Butkus

NEW YORK – Natera reported after the close of the market on Thursday a 52 percent year-over-year spike in its first quarter revenues on increased testing volumes and improvements in average test selling price. The Austin, Texas-based molecular diagnostics company also beat analysts' estimates on the top and bottom lines and increased its full-year revenue guidance.

Apr 30, 2024 | 360dx.com | Ben Butkus

BARCELONA, Spain – Saliva is a promising sample type for molecular diagnostic testing in infectious diseases beyond SARS-CoV-2, such as monkeypox and influenza, according to research presented at the European Society for Clinical Microbiology and Infectious Diseases global congress (ESCMID Global), held here this week.